For children with ADHD, participation in after-school activities is associated with reduced odds of moderate-to-severe ADHD.
In pediatric patients with ADHD, treatment with dasotraline 4 mg/day was effective in treating a range of ADHD-related symptoms and behaviors.
ADHD's many deficits cannot be ameliorated by pharmacotherapy alone. Researchers and clinicians are investigating computer interventions and physical activity that get to the root of the ADHD domain, such as inattention, memory, or time management.
The results of this study suggest that children prenatally exposed to substances should receive early mental health assessment.
These data confirmed the increased risk for psychiatric disorders in women with PCOS, and indicated an increased risk for ADHD and ASD in their children.
These results may be used to improve early identification of at-risk siblings based on a proband diagnosis of ADHD.
Recognizing the increased risk for mood disorders in children with ASD and ADHD may be useful for clinicians and parents in developing proper screening and treatment strategies.
If replicated, the novel findings in this study may have important implications for assessing sluggish cognitive tempo in ADHD.
Abstinence relieves symptoms associated with attention-deficit/hyperactivity disorder among patients with polysubstance use disorder.
Investigators sought to determine the risk for developing secondary ADHD 5 to 10 years after traumatic brain injury in children and adolescents.
Clinician awareness of this issue is essential in order to continue providing effective treatment while attempting to reduce abuse of these prescription drugs.
Researchers believe that the large increases in clinical ADHD diagnoses were unlikely to be representative of a real bump in prevalence.
These results may mitigate concerns by physicians regarding the pharmacological treatment of individuals with ADHD.
Antipsychotics have been shown to reduce tic severity, as has behavior therapy. However, the mechanisms behind the efficacy of behavior therapy have yet to be clarified by research.
Contrary to our expectation and the hypotheses put forward by Lulé et al., patients with ALS reported significantly lower rates of self-reported childhood ADHD, no difference in adult ADHD rates, and lower levels of attention deficit symptoms compared to the general population.
Medical costs for children with attention-deficit/hyperactivity disorder have consistently been determined to be higher than for those without the disorder, in part because of the frequency of comorbid conditions such as depression, anxiety, and substance abuse.
Investigators assessed cognition after long-term treatment with lisdexamfetamine dimesylate in children and adolescents with ADHD.
After a median of 25 years of follow-up, 2.4% of those born to a parent with a type 1 diabetes diagnosis were diagnosed with ADHD, compared with only 1.5% of the matched controls.
There is an increase in ADHD medication prescriptions in reproductive-aged women.
According to the FDA, Quillivant XR and ER are currently in shortage.
Weighing the benefits and risks of treatment options for ADHD in women of reproductive age is a clear priority.
These findings may raise new hypotheses for understanding the origins of ADHD, gender differences, and future targets in the prevention of ADHD.
Individual formulation-based CBT with usual treatment is more effective than usual treatment alone for improving core symptoms in ADHD.
Children whose fathers used SSRIs during the 3 months prior to conception were at an increased risk for ADHD compared with unexposed children.
A physician discusses their thoughts on the ADHD "epidemic."
ADHD in adults frequenly co-occurs with fibromyalgia syndrome, and FMS-related morbidity may be negatively impacted.
Cerebral morphometric alterations can differentiate between children with ADHD and controls.
Absolute increases in risks associated with stimulant use in women with ADHD are small.
There is a link between ADHD medication exposure during pregnancy and higher risk of neonatal morbidity.
In women with PsA, there is a higher prevalence of ADHD and depression.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Childhood-Onset Bipolar Disorder Associated With Impaired Family Functioning
- Valproate Use in Women Who Could Become Pregnant: The Argument for Informed Consent
- Review Examines the Effectiveness of Antidepressants for Insomnia
- Ketamine-Induced Dissociative Symptoms Predict Antidepressant Response
- Hospitalization Rates in Schizophrenia—Lurasidone vs Quetiapine
- Video Games and Exercise as Alternative Therapies for ADHD
- How Parents Can Enhance Autism Treatment: Use of Intervention Strategies at Home
- Electroconvulsive Therapy Effective in Children With Autism
- Comorbid Autism Spectrum Disorder and OCD: Challenges in Diagnosis and Treatment
- The Cutting Edge of Schizophrenia Research: VR as Treatment for Psychosis
- New APA President Takes Office as the First African-American to Lead the Organization
- "MDMA-Assisted Psychotherapy Effective for Treating PTSD in Veterans, First Responders "
- Early Intervention Services Superior to Treatment as Usual for Early-Phase Psychosis
- Depressive Symptoms Predict Future Pain, Disability in Adolescent JIA
- Gender-Related Association Between Physical Activity, Psychological Status in T2D